ENZYME INHIBITORS

Clinical trials for ENZYME INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new ENZYME INHIBITORS trials appear

Sign up with your email to follow new studies for ENZYME INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for Tough-to-Treat kidney cancer: targeted drug trial enters final phase

Disease control Ongoing

This study is testing a new targeted drug called savolitinib for people with an advanced form of kidney cancer called MET-driven papillary renal cell carcinoma (PRCC). It compares savolitinib directly against sunitinib, a standard treatment, to see which is better at controlling …

Matched conditions: ENZYME INHIBITORS

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

ENZYME INHIBITORS

Get alerted when new ENZYME INHIBITORS trials appear

New hope for Tough-to-Treat kidney cancer: targeted drug trial enters final phase